FDA Accused Of Slacking On Dietary Supplement Dangers

April 11, 2015 1:54 PM

2 0

Earlier this week, New York Times journalist Anahad O’Connor continued reporting on his investigation of the dietary supplement industry, this time calling into question the FDA’s apparent silence on a harmful amphetamine derivative in herbal products for weight loss, athletic performance, and mental concentration.

The editorial importance of the topic is evidenced by the article’s appearance on page A1 of Wednesday’s Times, albeit below the fold. And since O’Connor’s article, Vitamin Shoppe and other retailers have removed products from their shelves that tested positive for BMPEA.

Read more

To category page